Clinical Trials on Ovarian Neoplasms
Total 108654 results
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Zhongda HospitalNot yet recruitingOvarian Cancer, EpithelialChina
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
West China Second University HospitalNot yet recruitingRecurrent Ovarian CancerChina
-
Hospital Clinic of BarcelonaRecruitingAdvanced Ovarian CancerSpain
-
Xinhua Hospital, Shanghai Jiao Tong University...WithdrawnPlatinum-resistant Ovarian CancerChina
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)CompletedEpithelial Ovarian CancerDenmark, France, Germany, Italy, Spain, Poland, Belgium, Canada, United Kingdom, Israel, Norway
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
The Affiliated Hospital of Qingdao UniversityCompletedHigh-Grade Serous Ovarian CancerChina
-
PsiOxus Therapeutics LtdCompletedRecurrent Platinum Resistant Ovarian CancerUnited Kingdom, Spain
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...UnknownEpithelial Ovarian Cancer
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance
-
AGC Biologics S.p.A.CompletedOvarian Cancer Metastatic RecurrentItaly
-
Yonsei UniversityCompletedOvarian Cancer (Epithelial)Korea, Republic of
-
PharmaMar, SpainCompleted
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Chong Kun Dang PharmaceuticalCompletedEpithelial Ovarian CancerKorea, Republic of
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
New Mexico Cancer Care AllianceCelgene CorporationTerminatedOvarian Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
University of GlasgowCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest... and other collaboratorsTerminated
-
Liz-Anne LewsleyUnknownOvarian CancerUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian CancerUnited States
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)Completed
-
National Cheng-Kung University HospitalCompletedFallopian Tube Cancer | Peritoneal Carcinoma | Ovarian Neoplasms Malignant (Excl Germ Cell)
-
University of OklahomaGenentech, Inc.CompletedPrimary Peritoneal Carcinoma | Ovarian Carcinosarcoma | Advanced Ovarian CarcinomaUnited States
-
Bital Savir-BaruchBlue Earth DiagnosticsUnknownCervical Cancer | Ovarian Epithelial Cancer | Endometrial CancerUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical CenterRecruitingBRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Ovarian Neoplasm EpithelialNetherlands
-
University of PalermoNot yet recruitingBorderline Ovarian Tumor
-
M.D. Anderson Cancer CenterRecruitingOvarian Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Neoplasm | Low Grade Ovarian Serous Adenocarcinoma | Primary Peritoneal Low Grade Serous Adenocarcinoma | PsammocarcinomaUnited States
-
Grupo Español de Investigación en Cáncer de OvarioPharmaMarCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian CancerUnited States
-
Stanford UniversityTerminatedStage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Ovarian Germ Cell Tumor | Malignant Tumor of PeritoneumUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Nausea and Vomiting | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Stage IIA Fallopian Tube Cancer | Stage... and other conditionsUnited States
-
Alexandria UniversityRecruitingOvarian Epithelial CancerEgypt
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
ZIWIGMonitoring Force Group; iGenSeqRecruitingOvarian Cancer | Ovarian Cyst Benign | Borderline Ovarian CancerFrance
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Karolinska InstitutetKarolinska University Hospital; Umeå University; Leiden University; Dalarna University and other collaboratorsRecruitingNeoplasm, Breast | Neoplasm, Colorectal | Neoplasm, OvarianSweden
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Gastrointestinal Complication and other conditionsUnited States